Metis Global Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.79M | Sell |
61,267
-6,988
| -10% | -$775K | 0.18% | 99 |
|
|
2025
Q1 | $7.65M | Buy |
68,255
+7,244
| +12% | +$812K | 0.22% | 82 |
|
|
2024
Q4 | $5.64M | Sell |
61,011
-1,131
| -2% | -$104K | 0.17% | 99 |
|
|
2024
Q3 | $5.21M | Sell |
62,142
-371
| -0.6% | -$31.1K | 0.16% | 108 |
|
|
2024
Q2 | $4.29M | Buy |
62,513
+1,073
| +2% | +$73.6K | 0.15% | 115 |
|
|
2024
Q1 | $4.5M | Buy |
61,440
+1,770
| +3% | +$130K | 0.16% | 111 |
|
|
2023
Q4 | $4.83M | Sell |
59,670
-1,904
| -3% | -$154K | 0.19% | 95 |
|
|
2023
Q3 | $4.61M | Buy |
61,574
+12,545
| +26% | +$940K | 0.22% | 89 |
|
|
2023
Q2 | $3.78M | Sell |
49,029
-2,299
| -4% | -$177K | 0.2% | 101 |
|
|
2023
Q1 | $4.26M | Buy |
51,328
+7,043
| +16% | +$584K | 0.27% | 75 |
|
|
2022
Q4 | $3.8M | Buy |
44,285
+16,123
| +57% | +$1.38M | 0.34% | 62 |
|
|
2022
Q3 | $1.74M | Sell |
28,162
-808
| -3% | -$49.8K | 0.28% | 81 |
|
|
2022
Q2 | $1.79M | Buy |
28,970
+6,685
| +30% | +$413K | 0.29% | 79 |
|
|
2022
Q1 | $1.33M | Buy |
22,285
+8,888
| +66% | +$528K | 0.16% | 122 |
|
|
2021
Q4 | $973K | Buy |
+13,397
| New | +$973K | 0.27% | 85 |
|